The Health Resources and Services Administration should abandon its consideration of a 340B rebate model pilot program ...

LYNN– At a recent State House briefing hosted by the Massachusetts Health & Hospital Association, healthcare leaders gathered ...

Hospitals and clinics told regulators that switching to rebates in the 340B drug discount program would impose costs that ...

The 340B Drug Pricing Program must be reformed to better patient health and disincentivize institutional profit-seeking ...

Hospital and pharma groups have sharpened their spears for the rematch on 340B rebates.  | The administration's second stab ...

AHA urges HRSA to axe 340B model that would cost hospitals over $1 billion annually and increase administrative burdens.

While it may be hard to believe, there is one issue in Washington that meets the above criteria: fixing the 340B program.

In February 2026, the Department of Justice filed amicus briefs supporting pharmaceutical manufacturers, asserting that Rhode ...

AbbVie is spearheading a new battle in pharma’s long-running fight to reform the federal government’s 340B drug discount ...

Let’s talk about 340B, the drug pricing problem that you may not have heard of, but the one that seems to have swallowed the federal budget. The program started as an attempt to help hospitals that ...

New platform unifies data, automates workflows, and delivers predictive intelligence to help pharmacists and other health care providers maximize 340B performance, improve and accelerate patient ...

A new analysis from healthcare consulting firm Trilliant Health contains some grim news for people concerned about the plight ...